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Transient Elevations of Cytosolic Free Calcium
Retard Subsequent Apoptosis in Neutrophils In Vitro
Moira K. B. Whyte, * Simon J. Hardwick, * Laura C. Meagher, * John S. Savill, * and Christopher Haslettn
Departments of *Medicine (Respiratory Division) and tClinical Pharmacology, Royal Postgraduate Medical School, Hammersmith
Hospital, London W12 ONN; and §Department ofRespiratory Medicine, City Hospital, Edinburgh EHJO 5SB, United Kingdom
Abstract
Elevation of cytosolic calcium (ICa2+I;) has been reported to
induce apoptosis in a number of cell types. However, in the
neutrophil, which undergoes apoptosis constitutively during
aging in vitro, activation by inflammatory mediators elevates
ICa2Ji; and prolongs lifespan via inhibition of apoptosis. To
examine this paradox, we investigated the effects of modulation
of [Ca2" I upon apoptosis of neutrophils in vitro. Calcium iono-
phores (A23187, ionomycin) retarded apoptosis in neutrophil
populations after 20 h (P < 0.001). Conversely, intracellular
Ca2+-chelation, using bis-(o-aminophenoxy)-NNNN'-tetra-
acetic acid (BAPTA) acetoxymethyl ester (AM) promoted
apoptosis (P < 0.02). W-7 (an inhibitor of calmodulin) also
promoted apoptosis (P < 0.05). Measurements of ICa2+I,, us-
ing fura-2, showed (a) increased apoptosis in neutrophil popula-
tions was not associated with elevated ICa2I]1, (b) neutrophils
cultured with ionophore at concentrations inhibiting apoptosis
exhibited transient ( < 1 h) elevations of[Ca2Ijl, to levels previ-
ously reported with receptor-mediated stimuli, and (c) BAPTA
was able to prevent the elevation of ICa2+Ij and the inhibition of
apoptosis produced by ionophore. Modulation of apoptosis oc-
curred without alterations in intracellular pH. Thus, in the neu-
trophil, unlike lymphoid cells, elevation of ICa2+Ii exerts an
inhibitory effect upon apoptosis. Furthermore, these data sug-
gest that transient elevation of ICa2"I elicits signaling events
leading to prolonged inhibition of apoptosis. (J. Clin. Invest.
1993. 92:446-455.) Key words: programmed cell death * granu-
locyte * calcium ionophore * calcium chelation * calmodulin
Introduction
Apoptosis is a highly organized mechanism by which cells un-
dergo programmed cell death. In a wide range of cell types,
common morphological and molecular events bring about this
"physiological" death ( 1, 2). The morphological events char-
acterizing apoptosis are cytoplasmic and nuclear condensation
(3) and the biochemical "hallmark" is internucleosomal chro-
matin fragmentation (4). There has been intense interest in the
intracellular events mediating programmed cell death. In par-
ticular, previous studies in lymphoid cells have implicated in-
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creases in intracellular free calcium ([Ca2" ]i)' in the triggering
of apoptosis. For example, elevation of [Ca2" ]j, either directly
via calcium ionophore (5) or indirectly with "physiological"
stimuli, such as corticosteroids (6) or anti-CD3 receptor anti-
bodies (7), induces apoptosis in thymocytes. Similar data have
been obtained in other cell types, including leukemic T cell
lines (8) and cytotoxic T lymphocyte-induced target cell kill-
ing (9).
We have previously shown that neutrophils isolated from
peripheral blood, or inflamed sites, undergo apoptosis consti-
tutively during aging in vitro (10) and there is histological evi-
dence that neutrophils undergo apoptosis at inflamed sites in
vivo (10, 11). Neutrophil apoptosis determines the uptake of
intact neutrophils by macrophages ( 10, 12) and is associated
with specific deficits in neutrophil function, including loss of
ability to change shape (polarize) on deliberate stimulation
( 13). It has been proposed, therefore, that apoptosis represents
a mechanism for limiting the toxic potential ofthe neutrophil.
Nevertheless, while neutrophils undergo apoptosis constitu-
tively, the rate of apoptosis can itselfbe modulated. For exam-
ple, neutrophil apoptosis is delayed by bacterial products and
inflammatory mediators, such as FMLP and CSa (14), as well
as other receptor-mediated stimuli associated with calcium
mobilization and elevation of[Ca2+ ]i during neutrophil activa-
tion (15-17). These data raise an interesting paradox, that
apoptosis in the neutrophil is inhibited by stimuli increasing
[Ca2+ ]i, whilst this event has been shown to trigger apoptosis in
other cells.
We therefore examined the effects ofmodulation of [Ca2+]1
upon subsequent apoptosis in neutrophils in vitro, using cal-
cium ionophores, as used in previous studies (5, 6). We demon-
strated that incubation of neutrophils with calcium ionophores
(A23187, 4-bromo-A23187, and ionomycin) dramatically re-
tarded neutrophil apoptosis without inducing cell necrosis. We
observed that delay of apoptosis was associated with prolonga-
tion of functional lifespan ofthe neutrophil, assessed by stimu-
lated shape change and was also associated with a correspond-
ing delay in macrophage recognition. Conversely, neutrophil
apoptosis was promoted by chelation of intracellular calci-
um with bis-(o-aminophenoxy)-N,N,N,N'-tetraacetic acid
(BAPTA) acetoxymethyl ester (AM) or use of a calmodulin
inhibitor, W-7, with a corresponding reduction in neutrophil
function and increase in macrophage recognition. Measure-
ments of [Ca2+]i were used to examine changes in [Ca2+]i in
neutrophil populations during aging in vitro and after treat-
ment with ionophores and BAPTA/AM. Measurements of in-
1. Abbreviations used in this paper: BAPTA/AM, bis-(o-aminophen-
oxy)-N,N,N',N'-tetraacetic acid/acetoxymethyl ester; BCECF, 2',7'-
bis-(carboxyethyl)-5(6')-carboxyfluorescein; [Ca2+]1, intracellular free
calcium; MO, macrophages; pH,, intracellular pH.
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tracellular pH (pHi) were also performed. Transient elevation
of [Ca2" ]i resulted in prolonged inhibition of neutrophil apop-
tosis. Moreover, BAPTA/AM was able to prevent both the
elevation of [Ca2"]I and the inhibition of apoptosis produced
by ionophore.
Methods
Materials. All chemicals used were from Sigma Chemical Co. (Poole,
United Kingdom) unless otherwise indicated and were of the highest
grade purity available. Percoll and Ficoll were obtained from Pharma-
cia Fine Chemicals, Piscataway, NJ, sodium citrate from Pharma Ha-
meln GmbH, Hanover, Germany. Culture media (HBSS, Iscove's
DMEM) and supplements ( 100 U/liter penicillin and streptomycin)
were purchased from Gibco Laboratories, Grand Island, NY. Sterile
tissue culture plastic ware was purchased from Falcon Plastics,
Cockeysville, MD. Fura-2 acetoxymethyl ester (fura-2/AM), [2',7'-
bis-(carboxyethyl)-5(6')-carboxyfluorescein pentaacetoxymethyl)ester]
(BCECF/AM), BAPTA/AM, 4-bromo-A23187, and ionomycin were
obtained from Calbiochem (Novabiochem, Nottingham, United
Kingdom). A23 187 was purchased from Boehringer Mannheim
(Lewes, United Kingdom).
Neutrophil isolation and culture. Neutrophil granulocytes were iso-
lated from the peripheral blood of normal human volunteers by dex-
tran sedimentation followed by centrifugation through discontinuous
plasma-Percoll gradients as previously described ( 10, 18). These tech-
niques minimize activation or "priming" of neutrophils ( 18) and yield
granulocytes of > 98% purity on May-Giemsa-stained cytopreps. Eo-
sinophil "contamination" of neutrophil fractions was always < 2%.
Cells were suspended at concentrations of 5 X 106/ml in Iscove's DME
with 10% autologous platelet-rich, plasma-derived serum and with
penicillin and streptomycin (100 U/liter). The "age" of neutrophils in
culture was calculated designating this stage as time 0. Neutrophils
were incubated at 37°C in a 5% CO2 atmosphere and were harvested
from culture at various time points thereafter.
Treatment of neutrophils. Cells were incubated in the presence or
absence of a variety of potential modulators of apoptosis. These in-
cluded the calcium ionophores A23187, 4-bromo-A23187 (19), and
ionomycin; the calmodulin antagonist W-7 [N(6-aminohexyl)-5-
chloro-l-naphthalene sulfonamide, HC1] (20) and BAPTA/AM,
which chelates intracellular calcium (21 ). Stock solutions ofW-7 were
prepared in methanol (final concentration of methanol 0.05%, vol/
vol). Stock solutions of all other compounds were prepared in DMSO
(all final DMSO concentrations < 0.01%, vol/vol). Aliquots were di-
luted before each experiment in Iscove's DME. Preliminary experi-
ments confirmed that these concentrations of solvents did not increase
cell necrosis or modulate the rate of neutrophil apoptosis (data not
shown).
Assessment ofcell viability and morphology. At time 0 and then at
subsequent time points as indicated in Results, cells were removed
from culture and counted on a hemocytometer. Cell necrosis was as-
sessed by trypan blue exclusion and viability always exceeded 98%,
except where indicated below. Cell loss during culture was assessed by
counting on a hemocytometer and was minimal (< 1%). Cytocentri-
fuge preparations were fixed in methanol and stained (May-Giemsa
stain) for light microscopic evaluation of apoptosis, which previous
studies show to correlate closely with electron microscopy and DNA
electrophoresis ( 10). The percentage of cells demonstrating the highly
characteristic light microscopic appearances of apoptosis was assessed
by counting > 1,000 cells/slide. This was further confirmed by demon-
stration of a characteristic "ladder-pattern" of chromatin fragmenta-
tion.
Assay of neutrophil change of shape on stimulation. Neutrophil
ability to change shape upon stimulation was assessed using a previ-
ously described method ( 18). Neutrophils were incubated at 37°C for
15 min in the presence of FMLP (I100 nM). The cells were then fixed
by addition of an equal volume of 2% glutaraldehyde and the percent-
age of cells that had undergone change ofshape was assessed by count-
ing (> 500 cells). We have previously shown that apoptosis is asso-
ciated with loss of ability to change shape upon stimulation ( 13).
Chromatin fragmentation assays. The presence of chromatin frag-
mentation in aged neutrophils was assessed using a modification of a
method previously described for thymocytes (22). Briefly, aged neutro-
phils were washed twice in HBSS, then lysed with NTE ( 100mM NaCl,
10 mM Tris, 1 mM EDTA) buffer, pH 8, containing 1% SDS and
proteinase K (0.2 mg/ml). After incubation at 370C for 12 h, samples
were extracted twice with 1:1 (vol/vol) phenol and chloroform:iso-
amylalcohol (24:1, vol/vol). Samples were then precipitated in 80%
(vol/vol) ethanol at -20'C. The DNA was dissolved in 12 Ml TBE (89
mM Tris, 89 mM boric acid, 2 mM EDTA) buffer, pH 8.4, and to each
sample was added 3 Ml loading buffer containing 15% (wt/vol) Ficoll
400,0.5% (wt/vol) SDS, 50 mM EDTA, 0.05% (wt/vol) bromphenol
blue and 0.05% (vol/vol) xylene cyanol in TBE buffer. The samples,
together with XDNA (EcoRI) size markers, were loaded onto a 1%
(wt/vol) agarose gel containing ethidium bromide (30 jig/ml) and
electrophoresed at 50 V for 3 h then viewed with ultraviolet light.
Macrophage-neutrophil interaction assay. Recognition and inges-
tion of aged neutrophils by macrophages (MO) matured from human
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Figure 1. The effects of
the calcium ionophores
A23187 and ionomycin
upon the rate of neutro-
phil apoptosis, macro-
phage ingestion of neu-
trophils, and neutrophil
function in vitro. In five
experiments, neutro-
phils were incubated in
the presence or absence
of the calcium iono-
ph phores ionomycin (10
MiM) and A23187 (1
IM A23187 MM). (A) After 20 h in
culture both ionomycin
(hatched bar) and
A23187 (solid bar) had
greatly retarded apopto-
sis compared with un-
treated cells (open bar).
P < 0.001 in both cases.
(B) At 20 h ionomycin
(hatched bar) and
A23187 (filled bar) had
significantly reduced the
percentage of macro-
phages ingesting neutro-
F E phils (P <0.001 in both
IM A23187 cases). (C) Similar
modulation of neutro-
phil ability to undergo
stimulated shape change
at 20 h with ionomycin
and A23187 (P< 0.01
in both cases). Assess-
ment of freshly isolated
neutrophils (time 0) in
three of the five experi-
ments showed apoptosis
of 0.9±0.8%, macro-
phage recognition of
0.7±0.5%, and stimu-
lated shape change of
IM A23187 97.2±2.1%.
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Table I. Effects of Varying Concentrations ofA23187 upon Apoptosis and Cell Viability (Expressed as a Percentage
ofthe Control Population) after 20 h in Culture
A23187
Treatment Control 0.1IMM 0.5 IM I MM 2 MM 5 'M 10 M
Apoptosis
(Mean±SE%) 45.2±1.6 45.2±4 46.9±2.4 3.0±0.9 4.7±0.8 4.9±1.3 6.4±1.9
Viability
(Mean±SE%) 100 93.0±3 97.9±1.6 98.2±1.5 98±1.1 56.3±4.3 49.3±1.9
Results shown are means of three experiments, each counted in triplicate.
peripheral blood monocytes over 7 d was assayed as previously de-
scribed (10). Briefly, neutrophils were washed in HBSS, resuspended
at 1 X 106/ml in HBSS, and 1 ml of suspension was added to each well
of adherent Mk cultures in 24-well plates. After 30 min incubation at
370C in a 5% CO2 atmosphere, the wells were vigorously washed with
cold (40C) saline and fixed with 2% glutaraldehyde in PBS. To identify
ingested neutrophils, wells were then stained for myeloperoxidase us-
ing hydrogen peroxide and dimethoxybenzidine as substrate. The in-
teraction was quantified by counting, under light microscopy, the pro-
portion of M/i containing myeloperoxidase-positive cells in five ran-
domly selected fields. A minimum of 500 M,0 were assessed per well
and the percentage ingesting neutrophils recorded. A minimum of
three wells were counted per treatment and all neutrophil samples were
handled in the same way, regardless of their time in culture. Fresh and
aged control (nonmodulated) neutrophils were included as additional
controls.
Determination of cytosolic calcium levels [Ca2"];. [Ca2+]i was as-
sayed using a modification of the method described by Karnad et al.
(23). Briefly, neutrophils were removed from culture, washed three
times in HBSS without phenol red, and then incubated with fura-2/
AM (final concentration 2 ttM) for 30 min at 370C. After washing
away fura-2/AM and allowing a further 10 min for optimal deesterifi-
cation, neutrophils were resuspended at 2 x 106/ml in HBSS without
phenol red. Fluorescence was determined using a spectrofluorophotom-
eter (Shimadzu RF5000; V.A. Howe Ltd., London, United Kingdom)
with dual wavelength excitation (336 and 366 nm) and emission at 510
nm. Cells were stirred continuously at 370C. [Ca2+ ]i was calculated
using Labtime DWT software (V.A. Howe Ltd., London, United
Kingdom) from the relationship [Ca2+ ]i = Kd(R - Rmin)/(Rmax
- R).f (24): where [Ca2+]i is the cytosolic calcium concentration, R is
the ratio of fluorescence obtained at 336 and 366 nm in the cuvette
before calibration, RmaX is the ratio obtained in the presence of saturat-
ing [Ca2 ]i (after treatment with 50 gM digitonin), Rmin is the ratio
obtained in the absence of calcium (addition of 25 mM EGTA), Kd is
the dissociation constant for fura-2, taken as 224 nM at 370C (24), and
3 is the fluorescence ratio at 366 nm ofcells in the absence and presence
of calcium. The calcium ionophore, 4-bromo-A23187, was added di-
rectly to neutrophil suspensions in the cuvette in the fluorimeter (final
concentration 0.1-10 uM). In the time course experiments, where 4-
bromo-A23187 was added to the neutrophil suspensions in culture, the
cells were removed from culture at the time points indicated and then
washed twice before loading with fura-2/AM. 4-bromo-A23187 is non-
fluorescent at the wavelengths used to measure [Ca2+ ]i using fura-2
(19). In other experiments, cells were preincubated with the calcium
chelator BAPTA/AM (for 30 min at 370C) and again washed twice
before loading with fura-2/AM.
Determination ofpH,. pHj was measured by a method similar to
that described by Hartshorn et al. (25), using the acetoxymethyl ester
of the fluorescent probe BCECF. Neutrophils were incubated with
BCECF/AM (final concentration 5 ,M) for 30 min at 370C, washed,
and resuspended at 2 x 106/ml in HBSS without phenol red. Fluores-
cence was determined by dual ratio quantitation, with excitation at 506
and 455 nm and emission at 530 nm. The fluorescence ratio obtained
was related to pH, by linear regression analysis based on pH standards
as described (25), the relationship between fluorescence and pH, being
strictly linear only between pH 6.5 and 7.5. As with the [Ca2+]i mea-
surements, 4-bromo-A23 187 (final concentration 1-10 MM) was
added directly to neutrophil suspensions in the cuvette. In other experi-
ments, cells were preincubated with BAPTA/AM (for 30 min at 370C)
and washed twice before loading with BCECF/AM.
Statistical methods. Neutrophil apoptosis, shape change ability,
and cytosolic calcium measurements are given as mean±SEM. Con-
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Figure 2. Modulation of endogenous endonuclease activity by iono-
phore and BAPTA/AM. Electrophoresis ofDNA obtained from un-
treated cells and cells treated with A23 187 (1 AM) for 20 h, and
BAPTA/AM (2.5 MM and 5.0 MM) for 8 h. (A) A23187 treatment
prevented appearance of the characteristic ladder pattern of apoptosis
which was present in untreated cells at 20 h (after a 20-h incubation,
apoptosis was 45.2±1.6% in control and 3.0±0.9% in A23 187-treated
cells [P < 0.001], having been 0.9±0.8% in freshly isolated cells).
The right-hand lane contains standard DNA markers. (B) Con-
versely, DNA from BAPTA/AM-treated cells exhibited a ladder pat-
tern at 8 h which was absent from control DNA. The left-hand lane
contains standard DNA markers. (After an 8-h incubation, 2.5 ,M
BAPTA/AM increased apoptosis to 18.8±5.1% [mean±SEM, n
= 4, P < 0.02] and 5 AM BAPTA/AM to 45.0±8.2% [P < 0.001]
compared with 1.0±0.5% in the freshly isolated [time 01 cells and
9.8±3.9% in parallel control populations at 8 h).
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Figure 3. Modulation ofmacrophage phagocytosis ofaging neutrophils. (A) Recognition and ingestion of20-h control (untreated) neutrophils by
macrophages. A large number of myeloperoxidase-stained neutrophils can be seen within adherent macrophages. (B) 20-h neutrophils treated
with 1 tuM A23187, with almost complete inhibition of apoptosis (see text) are not recognized and ingested by macrophages. Scale bar = 25 pm.
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trol, ionophore-treated, W-7-treated, and BAPTA-treated cells from
the same neutrophil population were compared using paired t tests.
Results
Calcium ionophores inhibit neutrophil apoptosis. Exposure of
neutrophils to A23 187 (1 uM) and ionomycin (10 MM) pro-
duced a dramatic inhibition ofthe light microscopic features of
apoptosis at 20 h, compared with the control population. In
five experiments, apoptosis was 58.0±1.7% in control popula-
tions, 6.7±3.7% in A23 187-treated (P < 0.001 ), and 2.9±0.5%
in ionomycin-treated (P < 0.001 ) neutrophil populations at 20
h (Fig. 1). There was no significant cell necrosis (trypan blue
exclusion was always > 95%). A23 187 produced a concentra-
tion-dependent inhibition of neutrophil apoptosis (Table I).
The light microscopical evidence of reduced apoptosis was
confirmed in three ways. First, the characteristic "ladder-pat-
tern" upon electrophoresis of low molecular weight DNA (4)
was absent in ionophore-treated cells but present in DNA from
untreated cells (Fig. 2). Secondly, in interactions using control
and ionophore-treated cells, inhibition ofthe light microscopic
changes of apoptosis was correlated with a decrease in the per-
centage of macrophages ingesting neutrophils, which is known
to be dependent upon neutrophil apoptosis (Figs. 1 B and 3).
Thirdly, inhibition ofapoptosis was associated with an increase
in the percentage of neutrophils able to undergo stimulated
shape change; previous studies have shown that apoptotic neu-
trophils lose this property (Fig. 1 C). Modulation of the nu-
clear features of apoptosis was thus occurring concomitantly
with the functional and cell surface changes of apoptosis.
BAPTA/AM promotes neutrophil apoptosis. The inhibi-
tory effect of calcium ionophore suggested that Ca2" chelation
might promote apoptosis in aging neutrophils. This was tested
by studying neutrophils after 8 h in culture, so that increases in
apoptosis might more easily be detected than at later time
points, where a greater proportion of cells would already have
undergone this process. BAPTA/AM (a chelator of intracellu-
lar Ca2") produced a concentration-dependent promotion of
apoptosis (Table II), at concentrations that did not induce cell
necrosis, in keeping with our previous observation (10) that
neutrophils remain intact for some hours after the onset of
apoptosis. In three experiments, BAPTA/AM (2.5 ,M) signifi-
cantly increased apoptosis to 18.8±5.1% at 8 h, compared with
9.8±3.9% in parallel control populations (P < 0.02). A ladder
pattern ofchromatin fragmentation was demonstrated in DNA
from BAPTA-treated but not from control cells (Fig. 2).
Culture of neutrophils with ionophore induces a transient
rise in [Ca2+]i. Cytosolic Ca2+ levels, [Ca2+]i, were measured
Table II. Effects of Varying Concentrations ofBAPTA/AM
upon Apoptosis and Cell Viability after 8 h in Culture
BAPTA/AM
Treatment Control 0.5 AM 1.0 uM 2.5 pM 5.0 pM
Apoptosis
(Mean±SEM%) 9.8±3.9 10.1±3.0 9.5±3.6 18.8±5.1 45.0±8.2
Viability >99% >99% >99% >99% 96.5%
using the Ca2"-sensitive dye fura-2/AM in neutrophils ex-
posed to various concentrations of the ionophore 4-bromo-
A23187. These ranged from 0.5 MM, below which ionophore
had no effect upon apoptosis, to 5.0 MuM which profoundly
inhibited apoptosis at 20 h. Concentrations above 5.0,MM were
not used as these caused cell necrosis (Table I). We observed a
concentration-dependent elevation of [Ca2+]i levels when 4-
bromo-A23187 was added to the cuvette and [Ca2" ] continu-
ously monitored over 10 min (Fig. 4). The time course of
elevation of [Ca2+]i, in neutrophils exposed throughout to 1
,MM 4-bromo-A23187, is shown in Fig. 5. Resting [Ca2+ ]i val-
ues of 100 nM or below were obtained, consistent with findings
in other studies (15). 4-bromo-A23187 caused a rapid rise in
cytosolic calcium to a peak of 350-400 nM within 5 min, re-
turning to control levels by 1 h. It is important to note that after
20 h in culture [Ca2i]i was similar to that at the beginning of
culture, for both control and ionophore-treated cells, despite
the large differences in the proportion of apoptotic neutrophils
in the two populations (Table I). Thus, increased apoptosis in
neutrophil populations was not associated with elevated
[Ca2]ji measured in the population, by contrast with other
studies reporting progressive elevations in [Ca 2+ ]i in cells un-
dergoing apoptosis (5-7). However, aged neutrophils, whether
highly apoptotic, untreated cells, or ionophore-treated, still ex-
hibited ionophore-induced rises in [Ca21 ]i comparable to those
demonstrated in freshly isolated cells (Fig. 6). This suggests
that neither aging nor apoptosis of neutrophils was likely to
have an unforeseen, artifactual effect upon the ability of the
techniques used to follow changes in [Ca2+]i.
Stimuli altering [Ca2+ ]i in the neutrophil may also modu-
late intracellular pH (25). pHi was measured in neutrophils
loaded with the fluorescent indicator, BCECF/AM. Resting
pHi values of 7.37±0.03 were obtained (n = 8), comparable to
other studies (25). In three experiments, pH, was measured
after treatment of cells with 4-bromo-A23187. Over the time
Control
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Figure 4. Measurement of cytosolic calcium levels in freshly isolated
neutrophils in response to different concentrations of 4-bromo-
A23187. Cytosolic calcium measurements (nM) in fura-2-loaded,
freshly isolated neutrophils over 10 min. Various concentrations of
4-bromo-A23187 were added after 60 s, as indicated. These data,
from a single experiment, are representative of three experiments.
450 M. K B. Whyte, S. J. Hardwick, L. C. Meagher, J. S. Savill, and C. Haslett
Results shown are means of three experiments, each counted in trip-
licate.
with BAPTA/AM, at the start ofthe 8-h culture period (Fig. 9
D). In addition, BAPTA/AM prevented the inhibition of
apoptosis produced by ionophore. After 8 h, apoptosis was
9.2±1.2% in control cells, 1.2±0.6% in cells incubated with
A23187, 27.0±3.3% in cells incubated with BAPTA/AM, and
20.6±4.3% in cells incubated with both A23187 and BAPTA.
W- 7 promotes neutrophil apoptosis. To investigate a possi-
ble role for calmodulin in the effects of calcium ionophore on
apoptosis, neutrophils were treated with a calmodulin inhibi-
tor, W-7. Exposure of neutrophils to W-7 (60 itM) for 8 h
increased the percentage of apoptotic neutrophils to
^---q 24.0±8.5% compared with 7.1 ± 1.0% in parallel control popula-
tions (P < 0.05). This promotion of neutrophil apoptosis was
associated with corresponding increases in the percentage of
H-|||1} macrophages ingesting neutrophils and a reduction in the per-
0 1 2 3 4 20 centage of neutrophils able to undergo stimulated shape
time (h) change (Fig. 10). Again, there was no significant cell necrosisin these experiments.
Figure 5. Time course of cytosolic calcium levels in control and 1 4M
4-bromo-A23187-treated cells. Cytosolic calcium (nM, mean±SE
of triplicate measurements) in control (a) and 1 gM 4-bromo-
A23187-treated (A) neutrophils plotted against time (hours). Time
0 is immediately before addition of ionophore. At 20 h, apoptosis
was 71% in the control population and 23% in the ionophore-treated
cells. These data, from a single experiment, are representative of three
experiments.
Discussion
In these studies two calcium ionophores, A23187 and ionomy-
cin, markedly inhibited, in a concentration-dependent man-
ner, the rate of apoptosis (programmed cell death) in neutro-
course of the elevation of [Ca>2,, no change in pH, was ob-
served with 1 M 4-bromo-A23187, a concentration both pro-
foundly inhibiting apoptosis and elevating [Ca2>], (Fig. 7).
Furthermore, no alteration in pHi was seen at later time points
up to 3 h (data not shown). However, higher concentrations of
4-bromo-A23187 (5 MM and 10 MM), which were associated
with loss of neutrophil viability (Table I), did cause intracellu-
lar alkalinization (Fig. 7).
BAPTA/AM blocks the ionophore-induced Ca" spike and
inhibition ofapoptosis. Neutrophil suspensions were preloaded
with BAPTA/AM for 30 min at 370C at a range of concentra-
tions from 0.5 to 5 MM and [Ca2+] measured over 4 min (Fig.
7). BAPTA/AM at concentrations > 5 MM caused significant
cell necrosis (data not shown). Concentrations of < 2.5 ,M
had no effect upon cell necrosis or upon the percentage of
apoptotic cells after 8 h in culture (Table II). A concentration
of 2.5 MM BAPTA/AM, which had been shown to increase the
rate of neutrophil apoptosis, did not affect resting [Ca2+]i but
prevented elevation of [Ca2+2I in response to addition of iono-
phore to the cuvette (Fig. 8). 5MM BAPTA/AM, which caused
a greater promotion of apoptosis, lowered resting [Ca2+].
Although loading of cells with BAPTA/AM necessarily re-
leases acid because of cleavage of the parent ester (25, 26),
concentrations of BAPTA/AM of 2.5 MM or below did not
alter pH-. In three experiments, pH- was 7.37±0.04 in control
cells, 7.45±0.06 in cells incubated with 1 MM BAPTA/AM,
and 7.30±0.03 in cells incubated with 2.5 MM BAPTA/AM. 5
MM BAPTA/AM caused a slight lowering ofpH- to 7.25±0.04.
10MAM and 20AM BAPTA/AM lowered pH- to 7.12±0.14 and
6.83±0.34, respectively, comparable to published data (25).
In three further experiments, neutrophils were preincu-
bated for 8 h in the presence or absence of A23187, BAPTA/
AM, or both compounds. BAPTA/AM prevented elevation of
cytosolic calcium in response to 4-bromo-A23187, whether
added to the measuring cuvette (Fig. 9 C) or, added together
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Figure 6. Cytosolic cal-
cium levels in response
to further addition of 1
AM 4-bromo-A23 187.
(A) Fresh neutrophils
(0.8% apoptosis). (B)
20-h control (un-
treated) neutrophils
(54.1% apoptosis). (C)
20-h 1 AM 4-bromo-
A23 187-treated neutro-
phils ( 19.2% apopto-
sis). Cytosolic calcium
(nM) measured over
240 s, with 1 AM 4-
bromo-A23187 added
at 60 s, as indicated by
the arrows. Cell popula-
tions obtained from a
single donor. These
data, from a single ex-
periment, are represen-
tative of three experi-
ments.
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ng" in vitro. Conversely, a calcium chelator BAPTA/ lations. The elevation of [Ca2+ ]i was transient, but exerted a
noted neutrophil apoptosis, as did a calmodulin marked influence upon subsequent apoptosis and cell death.
W-7. That this was "true" apoptosis was shown by The relative contributions of intracellular and extracellular
lation of nuclear changes of apoptosis (light micro- sources of Ca2+ were not determined in these studies. The in-
ppearance and DNA fragmentation) with other tracellular calcium chelator BAPTA/AM prevented both the
vhich have been previously shown to correlate with elevation of [Ca2 ]i and the inhibition of apoptosis produced
loss of functional response to stimulation ( 13) and by ionophore. The modulating effects of both ionophore and
)n and ingestion by macrophages (10). These events BAPTA were observed at concentrations which did not alter
nined by apoptosis when it is constitutive and are not intracellular pH, although this was observed, together with loss
d from it in these modulating experiments. The cal- of cell viability, at higher concentrations of both compounds.
)phore 4-bromo-A23187 was shown to produce con- These data indicate that transient rises in [Ca2+ ]i can have
i-dependent elevation of [Ca2 ]i in neutrophil popu- profound and long-lasting effects upon as yet unknown signal-
ing pathways modulating endonuclease activation.
Neutrophil apoptosis leads to functional downregulation
Control and swift phagocytic clearance of senescent "unwanted" neu-
--- 0.5 jiM BAPTA/AM trophils. Characterization of the mechanisms of neutrophil
apoptosis is likely to have important implications for under-
--IfjM BAPTA/AM Ostanding ofthe lifespan and toxic potential ofthe neutrophil at
----- 2.5 pIM BAPTA/AM inflamed sites. Calcium mobilization and elevation of [Ca2 ]i
- 5 pM BAPTA/AM are recognized to be important mechanisms in receptor-me-diated activation of neutrophils. Physiologically relevant stim-
/ a_- '. uli, such as the chemotactic peptide, FMLP (15), the leuko-
/ 01.010,-' triene LTB4 (16), and interleukin-I (17), at concentrations
which induce cellular functions such as degranulation (17, 27)| e/a' _ -
~and respiratory burst (28 ), produce elevations of[Ca2+ I, equiv-
-_-----
alent to those seen in these experiments. The degree of neutro-
--a-- ---- ~ ~phil functional response does not directly relate to the elevation
of cytosolic calcium above resting levels since activation of
other signal transduction pathways also occurs (29). However,
I | - | ~ ,I the importance ofelevation of [Ca2+ ]i in neutrophil activation
O 50 100 150 200 250 has been shown by the ability of calcium ionophores to induce
time (sec) neutrophil activation, as assessed by superoxide anion genera-
tion (29, 30) and degranulation (27, 29), associated with ele-Measurements of cytosolic calcium in measured vations of (Ca 2+ i similar to those seen with physiological
tlons ofBAPTA/AM. Cytosolic calcium (nM) measured stiuliloaded, freshly isolated neutrophils over 240 s, the cells stImul .
en pretreated with various concentrations of BAPTA/AM In other cell types, however, elevated [Ca2+]I levels have
a at 370C. 1 ,AM 4-bromo-A23187 was added at 120 s as been implicated in triggering programmed cell death (apopto-
These data, from a single experiment, are representative of sis). Apoptosis is a type of cell death that occurs as a normal
riments. component ofdevelopment and of tissue homeostasis (3, 31 ).
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Figure 9. Measurements of resting cytosolic calcium levels and response to 1 ,uM 4-bromo A23187 in neutrophils preincubated for 8 h with
various compounds. (A) Control, untreated cells (9.0±1.2% apoptosis). (B) 1 gM 4-bromo-A23187 (1.2±0.6% apoptosis). (C) 2.5 ,uM
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Figure 10. The effect ofthe calmodulin inhibitor, W-7 (60 AM), upon
neutrophil apoptosis, macrophage ingestion of neutrophils, and neu-
trophil function in vitro. In four experiments, neutrophils were incu-
bated in the presence or absence of W-7 (60 gM). Assessment of
freshly-isolated (time 0) neutrophils in three of the four experiments
showed 0.7±0.6% apoptosis, 0.2±0.2% macrophage ingestion, and
98.5±1.5% stimulated change of shape. (A) After 8 h in culture,
apoptosis was promoted in W-7-treated compared with untreated
neutrophils (P < 0.05). (B) At 8 h, W-7 had significantly increased
macrophage ingestion of neutrophils (P < 0.001 ). (C) Similar mod-
ulation of neutrophil ability to undergo change of shape upon stimu-
lation (P < 0.05).
A wide range ofnucleated cells undergo apoptosis, but the pro-
cess has been most extensively studied in lymphoid cells. A
sterotyped sequence of events, including morphological and
biochemical changes, suggests an organized pathway to cell
death. Calcium has been implicated at two major stages in this
pathway; in the initiation of the apoptotic process and in the
final common pathway of activation of a calcium-dependent
endonuclease (2, 32). Calcium ionophores have been shown to
induce apoptosis in rat thymocytes (5), immature mouse thy-
mocytes (33) and in human leukemic T cell lines (8). Cyto-
toxic T lymphocyte-induced target cell death has been asso-
ciated with elevation of target cell [Ca2 ]i and similar eleva-
tions and subsequent cell death were produced by ionomycin
(9). Moreover, elevation of cytosolic calcium has been impli-
cated in the induction of apoptosis by both glucocorticoids (6)
and the toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (34) in im-
mature rat thymocytes. In the latter experiments, the appear-
ance of DNA fragmentation was preceded by elevation of
[Ca2+]i. Moreover, inhibition of the rise in [Ca2+]i was shown
to prevent subsequent DNA fragmentation. Elevation of
[Ca 2+ ]i may also, however, be a signal for clonal expansion and
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proliferation in mature thymocytes (35). Moreover, Rodri-
guez-Tarduchy et al. (36) have shown that A23187 inhibits
apoptosis induced by IL-3 deprivation in an IL-3-dependent
cell line, while also inducing cell cycle arrest.
The neutrophil's responses to elevation of [Ca 2+ ]i thus ap-
pear strikingly different. Neutrophils undergo apoptosis consti-
tutively with aging in vitro, but our studies show that an in-
creased proportion ofapoptotic cells within a population is not
associated with elevated [Ca2+ ]i (Fig. 5). Moreover, neutrophil
lifespan is prolonged, via the inhibition ofapoptosis, by inflam-
matory mediators such as FMLP, C5a, and IL-1 (14) at con-
centrations which are known to produce elevations of [Ca2+]i
in the neutrophil similar to those measured here ( 15-17). Al-
though the work of McConkey et al. (6) in lymphoid cells has
shown rapid induction of apoptosis with equivalent doses of
ionophores and equivalent elevations of [Ca2+]i, the rises in
[Ca2+]i levels have been sustained. By contrast, elevations in
the neutrophil were transient and [Ca2+]i had returned to rest-
ing levels by 1 h, despite the longer term effects upon the rate of
apoptosis.
The "downstream" signaling pathways of this modulation
ofapoptosis are also ofgreat importance and will be the subject
of further studies. Calmodulin is a multifunctional calcium-
binding protein involved in cell functions such as motility and
contractility, but also in the calcium-dependent regulation of
many enzymes (37). The ability ofW-7 to promote apoptosis
suggested that activation of a calcium:calmodulin dependent
kinase may play a role in the inhibition ofneutrophil apoptosis.
Although W-7 may have effects upon other intracellular trans-
duction systems, at the concentration of W-7 used in these
studies (60 ,uM) the predominant interaction ofW-7 is likely to
be with calmodulin rather than protein kinase-C (Ki 12 uM
calmodulin; Ki 110I M PK-C) (38). Thus, a weak effect on
PK-C cannot be excluded from these studies, but a more potent
effect ofW-7 upon calmodulin would be predicted. Again, the
converse effect, promotion of apoptosis, has been observed
with calmodulin inhibitor treatment of thymocytes (6), cal-
modulin perhaps being involved in regulating nuclear uptake
of calcium (39). Early induction of the calmodulin gene has
been reported in corticosteroid-induced apoptosis ofWEHI 7.2
lymphocytes, in which calmodulin inhibitors were also shown
to protect against apoptosis (40).
As shown in these studies, inhibition of apoptosis in the
neutrophil is linked to functional upregulation and delayed
macrophage removal. However, it is not unexpected that neu-
trophil mechanisms for control of apoptosis should differ from
those of other cells of the immune system. The terminally dif-
ferentiated neutrophil is short-lived (half-life in the circulation
- 6 h) and apparently destined to die rapidly by apoptosis
(41 ). Neutrophil activation, e.g., by inflammatory mediators,
not only enhances neutrophil functional capacity but also de-
lays the onset of apoptosis ( 14). Mechanisms may therefore
exist for the inhibition of constitutive neutrophil apoptosis,
linked to pathways of cellular activation, many of which are
mediated, at least in part, by elevation of cytosolic calcium.
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